Sjögren Syndrome without Focal Lymphocytic Infiltration of the Salivary Glands

REFERENCES

1. 1.↵
   1. Fox RI

   . Sjogren’s syndrome. Lancet 2005;366:321–31.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Al-Hashimi I,
   2. Khuder S,
   3. Haghighat N,
   4. Zipp M

   . Frequency and predictive value of the clinical manifestations in Sjogren’s syndrome. J Oral Pathol Med 2001;30:1–6.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Helmick CG,
   2. Felson DT,
   3. Lawrence RC,
   4. Gabriel S,
   5. Hirsch R,
   6. Kwoh CK,
   7. et al.

   Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58:15–25.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Vitali C,
   2. Bombardieri S,
   3. Jonsson R,
   4. Moutsopoulos HM,
   5. Alexander EL,
   6. Carsons SE,
   7. et al.

   Classification criteria for Sjogren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Shiboski CH,
   2. Shiboski SC,
   3. Seror R,
   4. Criswell LA,
   5. Labetoulle M,
   6. Lietman TM,
   7. et al;
   8. International Sjögren’s Syndrome Criteria Working Group

   . 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35–45.

   OpenUrl
6. 6.↵
   1. Rasmussen A,
   2. Ice JA,
   3. Li H,
   4. Grundahl K,
   5. Kelly JA,
   6. Radfar L,
   7. et al.

   Comparison of the American-European Consensus Group Sjogren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 2014;73:31–8.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Harris VM,
   2. Sharma R,
   3. Cavett J,
   4. Kurien BT,
   5. Liu K,
   6. Koelsch KA,
   7. et al.

   Klinefelter’s syndrome (47,XXY) is in excess among men with Sjogren’s syndrome. Clin Immunol 2016;168:25–9.

   OpenUrl
8. 8.↵
   1. Sharma R,
   2. Harris VM,
   3. Cavett J,
   4. Kurien BT,
   5. Liu K,
   6. Koelsch KA,
   7. et al.

   Rare X chromosome abnormalities in systemic lupus erythematosus and Sjogren’s syndrome. Arthritis Rheum 2017;69:2187–92.

   OpenUrl
9. 9.↵
   1. Danda D,
   2. Sharma R,
   3. Truong D,
   4. Koelsch KA,
   5. Kurien BT,
   6. Bagavant H,
   7. et al.

   Anti-La positive, anti-Ro negative subset of primary Sjogren’s syndrome: anti-La is a reality but is the disease? Clin Exp Rheumatol 2017;35:438–44.

   OpenUrl
10. 10.↵
    1. van Bijsterveld OP

    . Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10–4.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Whitcher JP,
    2. Shiboski CH,
    3. Shiboski SC,
    4. Heidenreich AM,
    5. Kitagawa K,
    6. Zhang S,
    7. et al.

    A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International Registry. Am J Ophthalmol 2010;149:405–15.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Daniels TE

    . Labial salivary gland biopsy in Sjogren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147–56.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Fisher BA,
    2. Jonsson R,
    3. Daniels T,
    4. Bombardieri M,
    5. Brown RM,
    6. Morgan P,
    7. et al.

    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren’s syndrome. Ann Rheum Dis 2017;76:1161–8.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Shiboski SC,
    2. Shiboski CH,
    3. Criswell L,
    4. Baer A,
    5. Challacombe S,
    6. Lanfranchi H,
    7. et al.

    American College of Rheumatology classification criteria for Sjogren’s syndrome: a data-driven, expert consensus approach in the Sjogren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012;64:475–87.

    OpenUrlCrossRef
15. 15.↵
    1. Shiboski CH,
    2. Shiboski SC,
    3. Seror R,
    4. Criswell LA,
    5. Labetoulle M,
    6. Lietman TM,
    7. et al;
    8. International Sjögren’s Syndrome Criteria Working Group

    . 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017;76:9–16.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Li H,
    2. Ice JA,
    3. Lessard CJ,
    4. Sivils KL

    . Interferons in Sjögren’s syndrome: genes, mechanisms, and effects. Front Immunol 2013;4:290.

    OpenUrlPubMed
17. 17.↵
    1. Li H,
    2. Reksten TR,
    3. Ice JA,
    4. Kelly JA,
    5. Adrianto I,
    6. Rasmussen A,
    7. et al.

    Identification of a Sjogren’s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet 2017;13:e1006820.

    OpenUrl
18. 18.↵
    1. de Hoon MJ,
    2. Imoto S,
    3. Nolan J,
    4. Miyano S

    . Open source clustering software. Bioinformatics 2004;20:1453–4.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Saldanha AJ

    . Java Treeview - extensible visualization of microarray data. Bioinformatics 2004;20:3246–8.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Seror R,
    2. Ravaud P,
    3. Bowman SJ,
    4. Baron G,
    5. Tzioufas A,
    6. Theander E,
    7. et al.

    EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 2010;69:1103–9.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Seror R,
    2. Bowman SJ,
    3. Brito-Zeron P,
    4. Theander E,
    5. Bootsma H,
    6. Tzioufas A,
    7. et al.

    EULAR Sjogren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015;1:e000022.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Emamian ES,
    2. Leon JM,
    3. Lessard CJ,
    4. Grandits M,
    5. Baechler EC,
    6. Gaffney PM,
    7. et al.

    Peripheral blood gene expression profiling in Sjogren’s syndrome. Genes Immun 2009;10:285–96.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Brito-Zeron P,
    2. Retamozo S,
    3. Gandia M,
    4. Akasbi M,
    5. Perez-De-Lis M,
    6. Diaz-Lagares C,
    7. et al.

    Monoclonal gammopathy related to Sjogren syndrome: a key marker of disease prognosis and outcomes. J Autoimmun 2012;39:43–8.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Kakugawa T,
    2. Sakamoto N,
    3. Ishimoto H,
    4. Shimizu T,
    5. Nakamura H,
    6. Nawata A,
    7. et al.

    Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjogren’s syndrome. Respir Med 2018;137:95–102.

    OpenUrl
25. 25.↵
    1. Risselada AP,
    2. Kruize AA,
    3. Goldschmeding R,
    4. Lafeber FP,
    5. Bijlsma JW,
    6. van Roon JA

    . The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren’s syndrome. Ann Rheum Dis 2014;73:1537–40.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Haldorsen K,
    2. Moen K,
    3. Jacobsen H,
    4. Jonsson R,
    5. Brun JG

    . Exocrine function in primary Sjogren syndrome: natural course and prognostic factors. Ann Rheum Dis 2008;67:949–54.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Bookman AA,
    2. Shen H,
    3. Cook RJ,
    4. Bailey D,
    5. McComb RJ,
    6. Rutka JA,
    7. et al.

    Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjogren’s syndrome but not patients with sicca. Arthritis Rheum 2011;63:2014–20.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Carubbi F,
    2. Alunno A,
    3. Cipriani P,
    4. Bartoloni E,
    5. Baldini C,
    6. Quartuccio L,
    7. et al.

    A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjogren’s syndrome. Lupus 2015;24:315–20.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Maier-Moore JS,
    2. Koelsch KA,
    3. Smith K,
    4. Lessard CJ,
    5. Radfar L,
    6. Lewis D,
    7. et al.

    Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjogren’s syndrome. Arthritis Rheum 2014;66:3445–56.

    OpenUrl
30. 30.↵
    1. Tengner P,
    2. Halse AK,
    3. Haga HJ,
    4. Jonsson R,
    5. Wahren-Herlenius M

    . Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren’s syndrome. Arthritis Rheum 1998;41:2238–48.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Davidson BK,
    2. Kelly CA,
    3. Griffiths ID

    . Primary Sjogren’s syndrome in the North East of England: A long-term follow-up study. Rheumatology 1999;38:245–53.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Teppo H,
    2. Revonta M

    . A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjogren’s syndrome. Clin Rheumatol 2007;26:1099–103.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Al-Hashimi I,
    2. Wright JM,
    3. Cooley CA,
    4. Nunn ME

    . Reproducibility of biopsy grade in Sjogren’s syndrome. J Oral Pathol Med 2001;30:408–12.

    OpenUrlCrossRefPubMed